Viewing Study NCT06481592


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-02-25 @ 6:59 PM
Study NCT ID: NCT06481592
Status: RECRUITING
Last Update Posted: 2025-10-30
First Post: 2024-06-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Sponsor: Iovance Biotherapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IOV-END-201
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators